Benchmark Electronics (BHE) Q1 2025: SemiCap Grows 18% as Supply Chain Shifts Drive New Bookings
Benchmark navigated a turbulent demand environment with standout SemiCap growth and resilient free cash flow, even as tariff uncertainty elongated sales cycles and pressured several end markets. The company’s diversified manufacturing footprint and sector mix provided ballast, with new program wins in industrial and A&D offsetting medical and computing softness. Management’s outlook signals sequential revenue recovery in the second half, but ongoing macro and customer supply chain recalibration will test execution and margin stability through 2025.
Summary
- Tariff Volatility Reshapes Demand Cycles: Customer supply chain moves and booking delays reflect global trade uncertainty.
- Resilient Sector Mix Offsets Weakness: SemiCap and A&D strength counterbalance softness in medical and computing.
- Second Half Growth Hinges on Channel Recovery: Sequential rebound depends on medical and computing normalization.
Performance Analysis
Benchmark Electronics delivered Q1 revenue of $632 million, down 6% year over year, with notable divergence across its key sectors. SemiCap, the semiconductor capital equipment manufacturing segment, surged 18% year over year and continued to outpace broader market growth, fueled by share gains and new program ramps. Aerospace and Defense (A&D) grew 15% year over year, with defense and space program momentum, while medical and Advanced Computing & Communications (AC&C) contracted double digits due to ongoing demand softness and delayed customer ramps.
Gross margin held above 10% for the sixth straight quarter, reflecting disciplined cost control and improved mix, even as operating margin compressed due to lower revenue. Free cash flow remained positive for the eighth consecutive quarter, supported by improved cash conversion cycle and working capital discipline. The company returned $14 million to shareholders through dividends and buybacks, while maintaining ample liquidity and a conservative leverage profile.
- SemiCap Momentum: 18% year-over-year growth in SemiCap, driven by new wins and share gains, outpaced industry averages.
- Medical and AC&C Headwinds: Medical revenue fell 12% sequentially, with AC&C down 12% on delayed HPC and 5G launches.
- Cash Flow Consistency: Free cash flow topped $27 million, with trailing 12-month free cash flow at $140 million, supporting ongoing capital returns.
Sector breadth and operational discipline provided a buffer against market-specific volatility, but margin expansion remains contingent on a return to top-line growth and normalization in lagging verticals.
Executive Commentary
"Our first quarter 2025 results demonstrated our continued operational focus despite the tariff-related market uncertainty that we faced late in the quarter... These challenges create opportunities for us as we help [customers] navigate this turbulence and optimize their global supply chain for the most efficient distribution of their products around the world."
Jeff Bank, CEO & President
"Despite the revenue headwinds among several of our end markets, we continue to focus on protecting gross margin, which again expanded year over year. Meanwhile, operating margin declined slightly, both sequentially and year over year."
Brian Shoemaker, CFO
Strategic Positioning
1. SemiCap Expansion and Geographic Diversification
SemiCap delivered another quarter of double-digit growth, with Benchmark leveraging its Penang, Malaysia and U.S. manufacturing footprint to win new programs and support domestic fab buildouts. The company broke ground on its fourth Penang facility, targeting vertical integration and future-ready capacity, while maintaining flexibility to serve medical and aerospace customers as needed.
2. Supply Chain Optimization as a Service
Tariff-driven supply chain recalibration is elongating sales cycles but also expanding Benchmark’s consultative role. With over 55% of manufacturing capacity in North America and 95% of products qualifying for USMCA, the company is positioned as a strategic partner for OEMs seeking to nearshore, reshore, or diversify production. This is driving new bookings and competitive takeaways, especially as OEMs rethink internal manufacturing versus outsourcing.
3. Sectoral Resilience and New Program Ramps
A&D and industrial bookings provided ballast, with defense and space demand robust and new industrial wins spanning digital displays, automation, and gaming subsectors. While industrial revenue was down slightly, bookings momentum reached a company high, setting up for future growth as new programs ramp and outsourcing trends accelerate.
4. Margin Protection and Capital Allocation Discipline
Management’s focus on mix, margin, and cash conversion cycle enabled gross margin stability above 10% despite revenue headwinds. Capital allocation balanced shareholder returns—$6.1 million in dividends and $8 million in buybacks—with investments in capacity and targeted M&A opportunities, primarily focused on high value-add, accretive capabilities rather than sector expansion.
5. Navigating Macro and Regulatory Uncertainty
Benchmark’s operational flexibility and global trade compliance team are mitigating the impact of shifting tariffs and executive orders. Management remains cautious, acknowledging that prolonged tariff uncertainty could further elongate customer decision cycles and delay revenue recovery in key verticals.
Key Considerations
Benchmark’s Q1 underscores a business model built for resilience, but not immune to sector-specific and macro shocks. The interplay of sector strength and weakness, coupled with global trade disruptions, is shaping both risk and opportunity for the remainder of 2025.
Key Considerations:
- Tariff Uncertainty Extends Sales Cycles: Customer hesitancy and scenario planning are elongating new program bookings, impacting near-term revenue visibility.
- Industrial and Medical Recovery Timing: Industrial bookings are strong, but revenue growth lags; medical sector recovery is expected in the second half as channel inventory normalizes and new wins ramp.
- Capacity Flexibility as a Competitive Edge: Ample U.S. and North American capacity enables Benchmark to capture incremental business as OEMs diversify supply chains.
- Capital Returns Balanced with Strategic Investment: Ongoing dividends and buybacks are complemented by targeted CapEx and selective M&A, with an emphasis on maintaining margin discipline and liquidity.
Risks
Prolonged tariff volatility and macroeconomic uncertainty could further delay customer decision-making and new program ramps, particularly in industrial and medical sectors. Margin stability remains vulnerable to top-line pressure, and competitive intensity in core verticals may increase as supply chains regionalize. Regulatory and geopolitical developments could also disrupt demand patterns and cost structures.
Forward Outlook
For Q2 2025, Benchmark guided to:
- Revenue of $615 to $665 million
- Non-GAAP gross margin of 10.2% to 10.4%
- Operating margin of 4.8% to 4.9%
- EPS of $0.52 to $0.58
For full-year 2025, management expects:
- First half revenue down mid-single digits year over year, with second half up mid-single digits
- Free cash flow to remain positive, with Q2 impacted by legacy tax payments
Management highlighted:
- Sequential growth expected throughout the balance of the year, barring a recession driven by tariffs
- Margin expansion contingent on revenue recovery in medical, industrial, and AC&C
Takeaways
Benchmark’s diversified sector exposure and supply chain expertise are enabling it to weather a turbulent macro and regulatory landscape, with SemiCap and A&D providing growth ballast. However, revenue headwinds in medical, industrial, and computing will test the company’s ability to sustain margin gains and free cash flow consistency as customers adapt to ongoing trade uncertainty.
- SemiCap and A&D Lead, but Recovery Requires Broader Sector Participation: Medical and AC&C must rebound for Benchmark to achieve full-year growth targets.
- Supply Chain Volatility Creates Both Risk and Opportunity: Benchmark’s consultative approach and flexible capacity position it for share gains as OEMs reevaluate global manufacturing footprints.
- Watch for Margin and Cash Flow Durability as Revenue Mix Shifts: Sustained gross margin above 10% hinges on normalization in lagging sectors and disciplined capital allocation.
Conclusion
Benchmark’s Q1 2025 results reflect a business in transition, balancing sectoral strength with pockets of weakness and macro-induced uncertainty. The company’s operational discipline and supply chain agility provide a foundation for second-half recovery, but execution risk remains elevated as customers and markets adapt to a shifting global trade environment.
Industry Read-Through
Benchmark’s results and commentary highlight a broader industry trend: global manufacturing and electronics supply chains are rapidly regionalizing in response to tariff volatility and geopolitical risk, driving both new outsourcing opportunities and elongated decision cycles. OEMs are increasingly seeking partners with flexible, multi-region capacity and supply chain advisory capabilities, a dynamic likely to benefit contract manufacturers with established North American and Southeast Asian footprints. Sector-specific demand remains uneven, with SemiCap and defense outperforming, while medical and high-performance computing lag—an industry pattern that could persist through 2025 as inventory and program ramps normalize.